No Impact of Probiotics to Reduce Clostridium difficile Infection in Hospitalized Patients: A Real-world Experience | Zendy

Maggie Box | Zendy; Kristine Ortwine | Zendy; Miguel Goicoechea | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

No Impact of Probiotics to Reduce Clostridium difficile Infection in Hospitalized Patients: A Real-world Experience

Author(s) -

Maggie Box,

Kristine Ortwine,

Miguel Goicoechea

Publication year - 2018

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofy192

Subject(s) - medicine , clostridium difficile , incidence (geometry) , probiotic , antibiotics , c difficile , lactobacillus , gastroenterology , intensive care medicine , microbiology and biotechnology , bacteria , physics , genetics , optics , biology

We assessed the effectiveness of a Lactobacillus probiotic on rates of health care facility–onset Clostridium difficile infection (HO-CDI) in patients receiving antibiotics. A total of 1576 patients were evaluated. There was no difference in the HO-CDI incidence between those who received probiotics and those who did not (1.8% vs 0.9%; P = .16).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research